Elevated Subclinical Double-Stranded DNA Antibodies and Future Proliferative Lupus Nephritis | Zendy

Stephen W. Olson | Zendy; Jessica J. Lee | Zendy; Lisa K. Prince | Zendy; Thomas P. Baker | Zendy; Patricia J. Papadopoulos | Zendy; Jess D. Edison | Zendy; Kevin C. Abbott | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Elevated Subclinical Double-Stranded DNA Antibodies and Future Proliferative Lupus Nephritis

Author(s) -

Stephen W. Olson,

Jessica J. Lee,

Lisa K. Prince,

Thomas P. Baker,

Patricia J. Papadopoulos,

Jess D. Edison,

Kevin C. Abbott

Publication year - 2013

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.01910213

Subject(s) - medicine , antibody , lupus nephritis , anti dsdna antibodies , subclinical infection , gastroenterology , immunology , lupus erythematosus , disease

Elevated anti-double-stranded DNA (dsDNA) antibody and C-reactive protein are associated with proliferative lupus nephritis (PLN). Progression of quantitative anti-dsDNA antibody in patients with PLN has not been compared with that in patients with systemic lupus erythematosus (SLE) without LN before diagnosis. The temporal relationship between anti-dsDNA antibody and C-reactive protein elevation has also not been evaluated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research